Notably, research indicates that individuals most interested in trying GLP-1 medications, and willing to accept common side effects, are those who report greater body shame, body surveillance, weight concerns, anti-fat bias, disordered eating behaviors, and higher BMIs, alongside lower body appreciation and body neutrality (Markey et al., 2025)
This means you may not experience the full therapeutic effect until you reach the maintenance dose
Gastroparesis is a disorder in which the stomach takes longer than usual to empty its contents into the small intestine
The formula leans on dermatologist-trusted ingredients to help soften the look of dark spots, hyperpigmentation, acne scars, and the general dullness that tends to creep in after long days, late nights or too much sun
Lindestam Arlehamn, Cecilia S
The critical path: TRIUMPH trials complete (Q2Q3 2026) Data analysis (34 months) NDA submission (Q4 2026 or Q1 2027) FDA review (610 months) Approval (late 2027 or Q1 2028) Launch preparation (13 months) Availability (Q1Q2 2028)